Tikun Therapeutics
www.tikuntherapeutics.com
c/o The Dysautonomia Foundation
315 W. 39th Street Suite 701
New York, NY 10018

Company Info
Phone(212) 279-1066
Year Established
2017
Contacts
Adam SachsPresident & CEO
Company Description
Tikun Therapeutics is an early-stage Public Benefit Corporation (PBC) wholly owned by the Familial Dysautonomia Foundation, supported by both grants and donations and focused on driving drug development for the ultra rare and progressive genetic disease familial dysautonomia (FD).